Brought to you by 
Panacos, National Cancer Institute in HIV drug deal
14 May 2001
Executive Summary
Panacos Pharmaceuticals (antiviral drugs and vaccines) and the National Cancer Institute will collaborate to discover potential drugs that prevent HIV infection by inhibiting the virus from entering human cells.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com